Caelyx in malignant mesothelioma: a phase II EORTC study.
about
The effect of internalizing human single chain antibody fragment on liposome targeting to epithelioid and sarcomatoid mesothelioma.Ribonucleases as a novel pro-apoptotic anticancer strategy: review of the preclinical and clinical data for ranpirnase.Chemotherapy for malignant pleural mesothelioma: past results and recent developments.First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial.Pegylated liposomal doxorubicin in malignant pleural mesothelioma: a possible guardian for long-term survival.Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma.Malignant intraperitoneal mesothelioma-Başkent University experience.Phase II trial of pegylated-liposomal doxorubicin (Doxil) in mesothelioma.Clinical phase II study of pegylated liposomal doxorubicin as second-line treatment in disseminated melanoma.
P2860
Q30498202-F9181458-F1D2-45DE-8D64-83C67DF6B595Q33227741-0C69C942-43DD-4BC2-843A-ECDB0FD5F6FDQ35074838-D228F9B1-6DFF-4D2E-A866-68EBC421436AQ35832320-FE1FFD08-2CA9-4D76-B38E-4C65305E8E04Q36295049-1FD528E9-FCAB-4B86-85E2-691FCBD12DBEQ36623383-E7CF340B-687C-453B-A3B6-87D7DFF706BDQ41891283-8C4B912D-225D-4E96-96D6-B15E983C7B65Q44115428-D4870369-B60B-49CE-B6FA-C4CC1605327FQ45183209-41ADB522-6B16-47CC-ACA6-F6DAB31A004E
P2860
Caelyx in malignant mesothelioma: a phase II EORTC study.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Caelyx in malignant mesothelioma: a phase II EORTC study.
@ast
Caelyx in malignant mesothelioma: a phase II EORTC study.
@en
Caelyx in malignant mesothelioma: a phase II EORTC study.
@nl
type
label
Caelyx in malignant mesothelioma: a phase II EORTC study.
@ast
Caelyx in malignant mesothelioma: a phase II EORTC study.
@en
Caelyx in malignant mesothelioma: a phase II EORTC study.
@nl
prefLabel
Caelyx in malignant mesothelioma: a phase II EORTC study.
@ast
Caelyx in malignant mesothelioma: a phase II EORTC study.
@en
Caelyx in malignant mesothelioma: a phase II EORTC study.
@nl
P2093
P356
P1433
P1476
Caelyx in malignant mesothelioma: a phase II EORTC study.
@en
P2093
P304
P356
10.1023/A:1008346925273
P577
2000-06-01T00:00:00Z